ciprofloxacin has been researched along with Endotoxin Shock in 29 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In this two-centre randomised clinical trial, critically ill patients with sepsis or septic shock were randomised to AutoKinetics dosing or standard dosing for four antibiotics: vancomycin, ciprofloxacin, meropenem, and ceftriaxone." | 5.51 | Right dose, right now: bedside, real-time, data-driven, and personalised antibiotic dosing in critically ill patients with sepsis or septic shock-a two-centre randomised clinical trial. ( Bosman, RJ; de Grooth, HJ; Driessen, R; Elbers, PWG; Fleuren, LM; Girbes, ARJ; Guo, T; Mathot, RAA; Roggeveen, LF; Swart, EL; Thoral, P; van den Bogaard, B; van Hest, RM, 2022) |
| "A case of a 73-year-old woman with acute renal failure due to toxic shock syndrome (TSS) is reported." | 2.39 | [A case of toxic shock syndrome (TSS) induced by methicillin-resistant staphylococcus aureus (MRSA) presenting as acute renal failure with disseminated intravascular coagulation]. ( Fujimoto, Y; Fukuuchi, F; Hida, M; Hiraga, S; Satoh, T, 1996) |
| "To describe the population pharmacokinetics of ciprofloxacin in septic shock and to define recommendations for effective ciprofloxacin dosing in these patients." | 1.51 | Defining optimal dosing of ciprofloxacin in patients with septic shock. ( Alobaid, AS; Lipman, J; Perner, A; Roberts, JA; Sjövall, F; Wallis, SC, 2019) |
| "We report a case of septic shock complicating transrectal ultrasound guided prostate biopsy despite antibiotic prophylaxis with ciprofloxacin." | 1.32 | Septic shock after transrectal ultrasound guided prostate biopsy. Is ciprofloxacin prophylaxis always protecting? ( Al-Assiri, M; Aronson, S; Binsaleh, S; Steinberg, A, 2004) |
| "We report the first case of toxic shock syndrome that has occurred after a loop electrosurgical excision procedure." | 1.29 | Toxic shock syndrome after loop electrosurgical excision procedure. ( Greenspoon, JS; Margolin, ML; Menashe, Y; Rosen, DJ, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.45) | 18.7374 |
| 1990's | 8 (27.59) | 18.2507 |
| 2000's | 7 (24.14) | 29.6817 |
| 2010's | 11 (37.93) | 24.3611 |
| 2020's | 2 (6.90) | 2.80 |
| Authors | Studies |
|---|---|
| Karabasevic, N | 1 |
| Roberts, JA | 2 |
| Stronach, L | 1 |
| Naicker, S | 1 |
| Wallis, SC | 2 |
| Sjövall, F | 2 |
| Sime, F | 1 |
| Roggeveen, LF | 1 |
| Guo, T | 1 |
| Fleuren, LM | 1 |
| Driessen, R | 1 |
| Thoral, P | 1 |
| van Hest, RM | 1 |
| Mathot, RAA | 1 |
| Swart, EL | 1 |
| de Grooth, HJ | 1 |
| van den Bogaard, B | 1 |
| Girbes, ARJ | 1 |
| Bosman, RJ | 1 |
| Elbers, PWG | 1 |
| Bianco, G | 1 |
| Boattini, M | 1 |
| Audisio, E | 1 |
| Cavallo, R | 1 |
| Costa, C | 1 |
| Alobaid, AS | 1 |
| Perner, A | 1 |
| Lipman, J | 1 |
| Jandhyala, D | 1 |
| Tan, EM | 1 |
| Stahr, DC | 1 |
| Sohail, MR | 1 |
| Josa Laorden, C | 1 |
| Gómez del Valle, C | 1 |
| Bucar Barjud, M | 1 |
| Amores Arriaga, MB | 1 |
| Torralba Cabeza, MA | 1 |
| Pérez Calvo, JI | 1 |
| Flinn, A | 1 |
| McDermott, M | 1 |
| Butler, KM | 1 |
| Friedl, C | 1 |
| Hackl, G | 1 |
| Schilcher, G | 1 |
| Rosenkranz, AR | 1 |
| Eller, K | 1 |
| Eller, P | 1 |
| Farhat, H | 1 |
| Chachaty, E | 1 |
| Antoun, S | 1 |
| Nitenberg, G | 1 |
| Zahar, JR | 1 |
| Preda, TC | 1 |
| Preda, VA | 1 |
| Mekisic, AP | 1 |
| Gashi, M | 1 |
| Raka, L | 1 |
| Ahmeti, S | 1 |
| Gashi, S | 1 |
| Dika, A | 1 |
| Gashi, G | 1 |
| Nakano, Y | 1 |
| Maybauer, MO | 1 |
| Maybauer, DM | 1 |
| Enkhbaatar, P | 1 |
| Traber, DL | 1 |
| Harji, DP | 1 |
| Rastall, S | 1 |
| Catchpole, C | 1 |
| Bright-Thomas, R | 1 |
| Thrush, S | 1 |
| Gaitán, JI | 1 |
| Bronze, MS | 1 |
| Popa, C | 1 |
| Wever, PC | 1 |
| Moviat, M | 1 |
| Mazloomi, E | 1 |
| Jazani, NH | 1 |
| Sohrabpour, M | 1 |
| Ilkhanizadeh, B | 1 |
| Shahabi, S | 1 |
| Webster, G | 1 |
| Schiffman, JD | 1 |
| Dosanjh, AS | 1 |
| Amieva, MR | 1 |
| Gans, HA | 1 |
| Sectish, TC | 1 |
| Hirata, N | 1 |
| Hiramatsu, K | 1 |
| Kadota, J | 1 |
| Nasu, M | 1 |
| Binsaleh, S | 1 |
| Al-Assiri, M | 1 |
| Aronson, S | 1 |
| Steinberg, A | 1 |
| Armengol, S | 1 |
| Moreno, JA | 1 |
| Xirgu, J | 1 |
| Torrabadella, P | 1 |
| Tomás, R | 1 |
| Peter, JV | 1 |
| Abraham, OC | 1 |
| George, S | 1 |
| Brahmadathan, KN | 1 |
| Mathai, D | 1 |
| Rosen, DJ | 1 |
| Margolin, ML | 1 |
| Menashe, Y | 1 |
| Greenspoon, JS | 1 |
| Miró, E | 1 |
| Navarro, F | 1 |
| March, F | 1 |
| Sanchez, F | 1 |
| Mirelis, B | 1 |
| Angel Blasco, M | 1 |
| Zaragoza, R | 1 |
| Soto, M | 1 |
| Alvarez, F | 1 |
| Fukuuchi, F | 1 |
| Hida, M | 1 |
| Fujimoto, Y | 1 |
| Hiraga, S | 1 |
| Satoh, T | 1 |
| Salon, EJ | 1 |
| Newbrough, MA | 1 |
| Albarracin, CA | 1 |
| Hernandez, JE | 1 |
| Khan, AA | 1 |
| Slifer, TR | 1 |
| Araujo, FG | 1 |
| Suzuki, Y | 1 |
| Remington, JS | 1 |
| Righter, J | 1 |
| Shenep, JL | 1 |
4 reviews available for ciprofloxacin and Endotoxin Shock
| Article | Year |
|---|---|
Waterhouse-Friderichsen syndrome due to Neisseria meningitidis infection in a young adult with thrombotic microangiopathy and eculizumab treatment: case report and review of management.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Ciprofloxacin; | 2017 |
Pseudomonal breast infection.
Topics: Abscess; Anti-Bacterial Agents; Ciprofloxacin; Drug Therapy, Combination; Female; Humans; Mastitis; | 2010 |
[New effects of antimicrobial agents other than antimicrobial activity].
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Antifungal Agents; Bacteria; Biofilms; Cip | 2003 |
[A case of toxic shock syndrome (TSS) induced by methicillin-resistant staphylococcus aureus (MRSA) presenting as acute renal failure with disseminated intravascular coagulation].
Topics: Acute Kidney Injury; Aged; Anti-Infective Agents; Antibiotics, Antitubercular; Bacterial Toxins; Cip | 1996 |
1 trial available for ciprofloxacin and Endotoxin Shock
| Article | Year |
|---|---|
Right dose, right now: bedside, real-time, data-driven, and personalised antibiotic dosing in critically ill patients with sepsis or septic shock-a two-centre randomised clinical trial.
Topics: Adult; Anti-Bacterial Agents; Ciprofloxacin; COVID-19; Critical Illness; Humans; Pandemics; Sepsis; | 2022 |
24 other studies available for ciprofloxacin and Endotoxin Shock
| Article | Year |
|---|---|
Use of the Hollow-Fiber Infection Model to Measure the Effect of Combination Therapy of Septic Shock Exposures of Meropenem and Ciprofloxacin against Intermediate and Resistant Pseudomonas aeruginosa Clinical Isolates.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Humans; Meropenem; Microbial Sensitivity Tests; Pseudomonas ae | 2022 |
Septic shock due to meropenem- and colistin-resistant Cupriavidus pauculus.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Colistin; Cupriavidus; Drug Resistance, Bacterial; Drug Therap | 2018 |
Defining optimal dosing of ciprofloxacin in patients with septic shock.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Area Under Curve; Chromatography, High Pressu | 2019 |
Disseminated
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Ciprofloxacin; Cryptococcosis; Cryptococcu | 2019 |
Septic shock due to Rhodococcus equi in a patient with chronic myelomonocytic leukemia.
Topics: Actinomycetales Infections; Aged; Anti-Bacterial Agents; Bacteremia; Ciprofloxacin; Diagnosis, Diffe | 2013 |
A Child With Septic Shock and Purpura.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Diagnosis, Differential; Drug Therapy, Combination; Female; Hu | 2016 |
[Two cases of Bacillus infection and immunodepression].
Topics: Amoxicillin; Anti-Bacterial Agents; Bacillus; Bacterial Infections; Ceftriaxone; Ciprofloxacin; Clav | 2008 |
Septic shock from penetrating leg injury with Vibrio vulnificus infection.
Topics: Aged; Anti-Infective Agents; Ciprofloxacin; Diagnosis, Differential; Female; Humans; Injections, Int | 2009 |
The impact of diagnostic delay on the course of septic shock caused by extended-spectrum-beta- lactamase-producing Escherichia coli.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefotaxime; Ciprofloxacin; Drug Resistance, Multiple, Bacter | 2009 |
A novel antibiotic based long-term model of ovine smoke inhalation injury and septic shock.
Topics: Animals; Anti-Bacterial Agents; Bacteremia; Ciprofloxacin; Disease Models, Animal; Female; Nitric Ox | 2010 |
Infection caused by Rahnella aquatilis.
Topics: Adult; Anemia, Sickle Cell; Anti-Bacterial Agents; Catheterization, Central Venous; Ciprofloxacin; E | 2010 |
H1N1 vaccination: expect the unexpected.
Topics: Aged; Anti-Bacterial Agents; Ciprofloxacin; Clostridium Infections; Clostridium septicum; Female; Fl | 2011 |
Synergistic effects of glutamine and ciprofloxacin in reduction of Pseudomonas aeruginosa-induced septic shock severity.
Topics: Animals; Ciprofloxacin; Drug Synergism; Drug Therapy, Combination; Glutamine; HSP70 Heat-Shock Prote | 2011 |
Jarisch-Herxheimer reaction associated with ciprofloxacin administration for tick-borne relapsing fever.
Topics: Adolescent; Animals; Anti-Infective Agents; Borrelia; Ciprofloxacin; Doxycycline; Female; Humans; Re | 2002 |
Septic shock after transrectal ultrasound guided prostate biopsy. Is ciprofloxacin prophylaxis always protecting?
Topics: Anti-Infective Agents; Antibiotic Prophylaxis; Biopsy, Needle; Ciprofloxacin; Endosonography; Humans | 2004 |
[Ciprofloxacin as a cause of a behavior disorder in a patient admitted into intensive care].
Topics: Adult; Ciprofloxacin; Clindamycin; Critical Care; Delirium; Drug Therapy, Combination; Hallucination | 1994 |
Toxic strep syndrome.
Topics: Cefazolin; Cellulitis; Ciprofloxacin; Drug Therapy, Combination; Humans; Male; Middle Aged; Shock, S | 1993 |
Toxic shock syndrome after loop electrosurgical excision procedure.
Topics: Adult; Ciprofloxacin; Electrosurgery; Female; Humans; Papillomaviridae; Postoperative Complications; | 1993 |
Emergence of different resistance mechanisms in Pseudomonas aeruginosa in a patient treated with imipenem.
Topics: Anti-Infective Agents; beta-Lactam Resistance; Ciprofloxacin; Humans; Imipenem; Microbial Sensitivit | 1995 |
[Septic shock caused by Escherichia coli resistant to a ciprofloxacin after extracorporeal shockwave lithotripsy].
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Escherichia coli; Female; Humans; | 1996 |
Anaphylactoid reaction to ciprofloxacin versus toxic shock syndrome.
Topics: Anti-Infective Agents; Ciprofloxacin; Diagnosis, Differential; Drug Hypersensitivity; Female; Humans | 1997 |
Protection against lipopolysaccharide-induced death by fluoroquinolones.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Cytokines; Death; Drug Interac | 2000 |
Pneumococcal meningitis during intravenous ciprofloxacin therapy.
Topics: Aged; Ciprofloxacin; Female; Humans; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Pneumoco | 1990 |
Antibiotic-induced bacterial cell lysis: a therapeutic dilemma.
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Bacteriolysis; Ciprofloxacin; Endotoxins; Esch | 1986 |